The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/Objective-Adventitia acts as an active participant in vascular inflammation but the precise mechanism underlying adventitia-mediated vascular inflammation is not fully understood. In this study, we sought to determine whether vascular endothelial growth factor (VEGF) regulates osteopontin (OPN) expression through Flt-1 in adventitial fibroblasts (AFs) to mediate vascular inflammation and neointima formation. Methods and Results-In primary cultured AFs, VEGF increased intracellular and secreted OPN expression in a timeand dose-dependent manner, which was effectively suppressed by a specific anti-Flt-1 hexapeptide. Interestingly, VEGF treatment of AFs enhanced the capability of AF-conditioned medium to stimulate macrophages chemotaxis, and this effect was attenuated after blockade of OPN from AF-conditioned medium. Furthermore, perivascular delivery of anti-Flt-1 peptide preferentially concentrated in the adventitia resulted in a decrease of neointima formation after balloon injury in carotid arteries. The inhibition of neointima formation was preceded by significant reduction of VEGF and OPN expression with concurrent macrophage infiltration into adventitia after injury. Activation of extracellular signalregulated kinase 1/2 pathway was involved in OPN upregulation and macrophage chemotaxis. Conclusion-These results demonstrate that VEGF/Flt-1 signaling plays a significant role in vascular inflammation and neointima formation by regulating OPN expression in AFs and provide insight into Flt-1 as a potential therapeutic target for vascular diseases. (Arterioscler Thromb Vasc Biol. 2012;32:2250-2258.)
V ascular inflammation significantly contributes to cardiovascular diseases, such as atherosclerosis, 1 hypertension, 2 and abdominal aortic aneurysm. 3 Growing experimental evidence indicates that vascular inflammation is initiated in adventitia and progresses inward toward the intima. 4 After vascular injury, activated adventitial fibroblasts (AFs) rapidly upregulate the production of cytokines, chemokines, and adhesion molecules, and before established disease the adventitia and perivascular tissue become highly populated with neutrophils, macrophages, and apoptotic cells. [5] [6] [7] Vascular endothelial growth factor (VEGF) highly expressed in vascular endothelial cells functions as an angiogenic factor of neonatal and postnatal vascular formation, which has been typically considered to exert its biological signaling mainly through 2 tyrosine kinase receptors, Flt-1 and Flk-1. [8] [9] [10] Earlier studies indicated that Flt-1 is a nonfunctional decoy receptor for VEGF and negatively regulates VEGF/Flk-1 signaling for angiogenesis. 11 However, recent data demonstrated that Flt-1-mediated signals stimulate angiogenesis and inflammation by predominant action on nonendothelial cell types. [11] [12] [13] Importantly, Flt-1 is involved in several important inflammatory diseases, such as rheumatoid arthritis, 14, 15 cancer metastasis, 16 and atherosclerosis. 14 Our previous studies indicated that Flt-1, but not Flk-1, exists in AFs, which is increased in the adventitia of injured arteries. 17 However, the mechanism of adventitia-mediated vascular inflammation regulated by Flt-1 is not fully understood.
Osteopontin (OPN) is an arginine-glycine-aspartatecontaining extracellular matrix phosphoprotein mediating diverse cellu lar funct ions, such as adhesion, 18 migration, 19 and prevention of apoptosis, 20 which is implicated in the pathogenesis of a variety of disease states, including atherosclerosis, cancer, chronic inflammatory, and autoimmune diseases. 21 In addition, OPN, specifically localized in and around inflammatory cells, serves as a chemotactic molecule to promote the migration of inflammatory cells to the wound site and acts as an adhesive protein to retain cells at the site and regulate cytokine production in macrophages, dendritic cells, and T cells. 22 Moreover, recent studies revealed that OPN expression is induced by many growth factors and cytokines involved in vascular remodeling and inflammation, such as angiotensin II, 23, 24 fibroblast growth factor-2, 25 plateletderived growth factor, 26, 27 and interleukin-1. 28 Therefore, the regulation of OPN expression seems to play a key role in vascular inflammation.
Adventitia plays a crucial role in the genesis and maintenance of vascular inflammation in cardiovascular diseases. [29] [30] [31] Consequently, understanding the processes controlling recruitment of inflammatory cells in the adventitia might provide fundamental insights into the vascular inflammation. Our previous work showed that increased expression of Flt-1 and OPN is associated with arterial injury in adventitia. 17, 24 Therefore, the present study aimed to determine whether VEGF stimulates OPN expression through Flt-1 by exerting a chemotactic effect on macrophage in AFs and explore the role of Flt-1 in adventitia-mediated vascular inflammation and subsequent neointima formation after balloon injury.
Materials and Methods

Chemotaxis Assay
The isolation and culture of AFs from the thoracic aortas of 6 to 8 week-old male Sprague-Dawley rats has been previously described. 17 These cells were characterized by positive staining for vimentin and negative staining for α-smooth muscle actin as described previously. 32 Quiescent AFs were stimulated by different concentrations of VEGF and AF-derived conditioned medium were collected for macrophage chemotaxis in transwell chamber.
Animal Model
Male 12 to 14-week-old Sprague-Dawley rats weighing ≈350 to 400 g were used in the present study (6-8 rats per group). Immediately after the balloon injury procedure, 200 mL of pluronic gel containing anti-Flt-1 peptide or reverse peptide (as a negative control) was applied to the adventitial surface of injured arteries. Arteries were harvested on day 14 for histological and immunohistochemical analyses. All animal procedures were approved in accordance with the institutional guidelines established by the Committee of Ethics on Animal Experiments at the Chinese Academy of Sciences. Other methods are detailed in the online-only Data Supplement.
Results
VEGF-Induced OPN Expression
To examine the effect of VEGF on OPN expression, Western blot and ELISA measurement were used to determine OPN protein expression in the cell lysate and OPN secretion in AF-conditioned medium after stimulation of AFs with VEGF, respectively. VEGF upregulated intracellular and secreted OPN protein levels in a dose-and time-dependent manner, with maximal effect at 10 ng/mL ( Figure 1A-1D ). To determine the Flt-1 dependence of VEGF-induced OPN expression, we Figure 1 . Vascular endothelial growth factor (VEGF)-induced osteopontin (OPN) expression is Flt-1-dependent. Quiescent adventitial fibroblasts (AFs) were stimulated by various concentrations of VEGF for 8 hours (A) or with 10 ng/mL VEGF for various times (B). *P<0.05, **P<0.01 vs control. Intracellular OPN expression was analyzed by Western blot. AF-conditioned medium was obtained from AFs stimulated by various concentrations of VEGF for 24 hours (C) or with 5 ng/mL VEGF for various times (D). Secreted OPN expression was analyzed by ELISA analysis. *P<0.05, **P<0.01 vs control. Quiescent AFs were treated with 10 ng/mL of VEGF for 8 hours (E) or 24 hours (F). Where indicated, AFs were pretreated for 1 hour with 100 µmol/L anti-Flt-1 peptide or 100 µmol/L reverse peptide. *P<0.05, **P<0.01 vs VEGF. G, Quiescent AFs were stimulated by 10 ng/mL VEGF for 5 minutes. Where indicated, AFs were pretreated for 1 hour with 100 µmol/L anti-Flt-1 peptide or 100 µmol/L reverse peptide. Cell lysates were immunoprecipitated with an anti-Flt-1 antibody. The immunoprecipitated proteins were subjected to Western blot analysis using either anti-phosphotyrosine or anti-Flt-1 antibody. IP indicates immunoprecipitation.
used a specific anti-Flt-1 hexapeptide (Gly-Asn-Gln-Trp-Phe-Ile or GNQWFI). 33 The anti-Flt-1 peptide selectively binds to Flt-1 and thus inhibits the interaction of VEGF with Flt-1 specifically. 33 The reverse peptide (Ile-Phe-Trp-Gln-Asn-Gly or IFWQNG) was used as a negative control. We found that both intracellular and secreted OPN induction by VEGF was almost completely inhibited by pretreatment of AFs with anti-Flt-1 peptide, but not reverse peptide ( Figure 1E and 1F) .
Furthermore, to verify the role of anti-Flt-1 peptide in Flt-1 activation, we investigated tyrosine phosphorylation of Flt-1 in AFs. Immunoprecipitation results showed that 10 ng/mL VEGF induced Flt-1 activation, which was attenuated by anti-Flt-1 peptide ( Figure 1G ). These results indicate that VEGF regulates OPN protein expression through its receptor Flt-1.
VEGF/Flt-1 Signaling Regulates Macrophage Chemotaxis and Is OPN-Dependent
To determine the interaction of fibroblast with macrophage, we examined the effects of VEGF treatment of AF-derived conditioned medium on macrophage chemotaxis using a transwell chamber migration assay. VEGF dose dependently enhanced the capacity of AF-conditioned medium-stimulated macrophage chemotaxis ( Figure 2A ). Pretreatment of AFs with anti-Flt-1 peptide markedly inhibited the effect of AFconditioned medium on macrophages chemotaxis ( Figure 2B ). To further elucidate the OPN dependence of VEGF-induced macrophage chemotaxis, an OPN-neutralizing antibody was used to block OPN activity. Notably, we found that pretreatment of AF-conditioned medium with OPN-neutralizing antibody resulted in a decrease of macrophage chemotaxis, which is consistent with immunodepletion of OPN from AF-conditioned medium ( Figure 2C ; and Figure I in the online-only Data Supplement). Together, these results suggest that AF-derived OPN is a critical mediator of VEGF/Flt-1induced macrophage chemotaxis.
Effect of Anti-Flt-1 Peptide on Neointima Formation After Balloon Injury
To investigate the role of Flt-1 signaling in neointima hyperplasia in vivo, the effect of the specific anti-Flt-1 peptide on neointima formation of carotid arteries induced by balloon injury was examined. The peptides were applied perivascularly around the adventitia of injured arteries mixed with pluronic F127 gel. As shown in Figure 3A , the injured arteries with or without the reverse peptide developed significant neointima formation consisting mostly of stellate cells and extracellular matrix by day 14 after injury. However, the treated arteries from the local delivery of anti-Flt-1 peptide showed much less neointima formation and luminal narrowing suggesting that Flt-1 signaling pathway in adventitia is involved in vascular remodeling. The quantitative histomorphometry results of neointimal area, intima to media (I/M) ratio, and lumen area on day 14 after injury are shown in Figure 3B .
Effect of Anti-Flt-1 Peptide on OPN and VEGF Expression
Immunofluorescent double staining revealed that VEGF and OPN were predominantly expressed in adventitia during the early phase (day 1 and 3) and in all 3 layers (neointima, media, and adventitia) during the later phase (days 7 and 14) after injury ( Figure 4A ). Interestingly, most VEGF-positive cells were also stained with OPN, especially in the neointima and adventitia ( Figure 4B ). The induction of VEGF and OPN were markedly suppressed by the anti-Flt-1 peptide treatment compared with injury or the reverse peptide group ( Figure 4B and 4C). Moreover, exogenous VEGF enhanced VEGF mRNA expression in AFs, which was attenuated by anti-Flt-1 peptide by using multiplex polymerase chain reaction ( Figure IIA and IIB in the online-only Data Supplement). These findings demonstrate that VEGF and OPN are distributed in the vascular adventitia from the early phase to the later phase, suggesting that an autocrine mechanism of VEGF regulates OPN expression via Flt-1 in vivo especially in adventitia.
Effect of Anti-Flt-1 Peptide on Inflammatory Response and Proliferation after Balloon Injury
Next, we examined macrophage infiltration into injured arteries by detecting CD68-positive macrophages. Macrophages were predominantly localized in adventitia during the early phase and in both neointima and adventitia by day 14 ( Figure 5A ). However, macrophage accumulation was dramatically reduced in adventitia by perivascular treatment with the anti-Flt-1 peptide compared with injury or the reverse peptide group ( Figure 5B and 5C ), indicating that Flt-1 signaling is involved in macrophage infiltration into injured arteries.
We then investigated the effect of anti-Flt-1 peptide on proliferation of vascular wall cells after injury. In Figure 5A , ki-67-positive cells dramatically increased in adventitia at day 1 and in all 3 layers from day 3 to day 14 after injury ( Figure 5D ). The anti-Flt-1 peptide effectively decreased the number of ki-67-positive cells, which are mainly distributed in adventitia, suggesting that anti-Flt-1 peptide strongly inhibits cell proliferation ( Figure 5E and 5F).
ERK1/2 Pathway Is Involved in OPN Expression
As shown in Figure 6A , treatment of AFs with VEGF (10 ng/mL) increased the phosphorylation of extracellular signalregulated kinase (ERK) 1/2 with peak at 5 minutes and declined thereafter ( Figure III in the online-only Data Supplement). Phosphorylation of ERK1/2 was significantly attenuated by pretreatment of AFs with the anti-Flt-peptide but not the reverse peptide ( Figure 6B ). Furthermore, we found that VEGF-induced OPN expression was significantly attenuated by pretreatment of AFs with ERK1/2 inhibitor PD98059 ( Figure 6C ). Migration assay showed that AF-conditioned medium collected by AFs pretreated with ERK1/2 inhibitor PD98059 followed by VEGF stimulating effectively inhibited macrophages chemotaxis ( Figure 6D ). To evaluate ERK1/2 activation in injured arteries, we performed immunostaining of phospho-ERK1/2. The expression level of phospho-ERK1/2 was reduced at both the adventitial and neointimal layers of the arteries treated with anti-Flt-1 peptide compared with injury or the reverse peptide group (Figure 6E and 6F ). In addition, phospho-ERK1/2 and OPN were colocalized in injured arteries suggesting that ERK1/2 pathway is involved in OPN expression in vivo ( Figure 6G ).
Discussion
The major finding of this study is that VEGF/Flt-1 signaling plays a critical role in the promotion of the adventitia-mediated vascular inflammation by regulating OPN expression, which is a key process in the development of vascular remodeling. Specifically, we demonstrated that OPN is upregulated in response to VEGF in AFs participating in macrophages chemotaxis. Moreover, perivascular delivery of anti-Flt-1 peptide remarkably attenuates neointima formation after injury, which is preceded by significant reduction of VEGF and OPN expression and macrophage infiltration into adventitia. These results suggest that blockade of VEGF/Flt-1 signaling suppresses vascular inflammation, as well as experimental restenosis, at least partly via inhibition of macrophages recruitment in an OPN-dependent manner.
Growing evidence demonstrated that Flt-1 exerts its biological function on nonendothelial cell types, which was previously considered as a nonfunctional decoy receptor in endothelial cells. 11 Here, we showed that Flt-1 is a functional receptor, which mediates VEGF-induced OPN expression through ERK1/2 pathway in AFs. It is reported that OPN is not expressed in circulating monocytes but is one of the most abundant proteins expressed by macrophages and is a potent macrophage-chemotactic mediator. 22 Additionally, OPN can induce chemokine expression mediating inflammatory response, which is a highly coordinated process involving multiple factors acting in a complex network as stimulators. 34, 35 Seipelt et al 36 found that OPN is substantially upregulated in the VEGF-treated aortas, suggesting the important role of VEGF in inflammatory response. Furthermore, VEGF directly induces macrophage chemotaxis by Flt-1-mediated mechanisms. 37 Taken together, it is reasonable to hypothesize that VEGF/Flt-1 signaling-induced AF-derived OPN is involved in macrophage chemotaxis. Figure 6 . Extracellular signal-regulated kinase (ERK) 1/2 activation. A, Quiescent adventitial fibroblasts (AFs) were stimulated with 10 ng/mL vascular endothelial growth factor (VEGF) for the indicated times and phosphorylation of ERK1/2 was examined. B, Quiescent AFs were treated with 10 ng/mL of VEGF for 5 minutes. Where indicated, AFs were pretreated for 1 hour with 100 µmol/L anti-Flt-1 peptide or 100 µmol/L reverse peptide and phosphorylation of ERK1/2 (p-ERK) was examined. Total ERK1/2 (t-ERK) was used as internal controls. C, VEGF-induced OPN expression for 8 hours was evaluated by pretreatment of AFs with 10 μmol/L ERK1/2 inhibitor PD98059. D, Quiescent AFs were treated for 24 hours in the 10 ng/mL of VEGF. Where indicated, AFs were pretreated for 1 hour with 10 μmol/L ERK1/2 inhibitor PD98059. Chemotaxis of macrophage in response to the stimulation of AF-conditioned medium for 1.5 hours was evaluated in transwell system. **P<0.01 vs VEGF. E, Immunostaining staining of p-ERK1/2 (in red) in carotid arteries of sham group, injury 14 days and injury with anti-Flt-1 peptide or reverse peptide for 14 days. Indeed, our results demonstrated that VEGF-treated AFs markedly enhanced AF-conditioned medium-induced macrophage chemotaxis, which is mediated via activation of VEGF/Flt-1 signaling and induction of OPN expression. Therefore, these studies suggest both a direct and an indirect effect of VEGF/ Flt-1 signaling on macrophage chemotaxis might accelerate vascular inflammation after vascular injury.
In previous studies, the effects of VEGF on neointima formation have been inconsistent, which appears depending on the methods of VEGF gene transfer, the species, and the mode of injury. 11 For example, Khurana et al 38 reported that adenovirus-mediated VEGF gene transfer exacerbates neointima formation in rabbit periadventitial collar replacement model. On the contrary, Hutter et al 39 found that intravenous injection of VEGF adenovirus accelerates endothelial repair and inhibited neointima formation in mouse wire injury model. These studies tested whether regulation of VEGF signaling affects the process of neointima formation, but few studies specifically focused on Flt-1. We found that perivascular blockade of Flt-1 signaling markedly attenuates neointima formation. However, Koga et al 40 showed that there is no significant difference in neointima formation after wire injury between wild-type and Flt-1-kinase domain-deleted mice, in which Flt-1 kinase activity and downstream signaling pathway are completely blocked. 8 Nevertheless, unlike systemic lack of Flt-1 signaling, we use an anti-Flt-1 hexapeptide (GNQWFI) by perivascular delivery after injury to specifically block VEGF-induced Flt-1 signaling. The specific anti-Flt-1 peptide, which was screened from synthetic peptide library that inhibits VEGF/Flt-1 interaction, does not show any effect on the VEGF/Flk-1 interaction. 33 It is also reported that the anti-Flt-1 peptide inhibits tumor growth and suppresses the effect of placenta growth factor and Flt-1 on rheumatoid inflammation, which further demonstrates the specificity of the peptide. 15, 33 Moreover, several previous studies have suggested that perivascular transfer of exogenous genes primarily affect adventitial cells but not vascular smooth muscle or endothelial cells and provide evidence that adventitial cell migrates through the media to neointima after injury. [41] [42] [43] Therefore, the contribution of Flt-1 on VEGF-mediated regulation of neointima formation might be because of inflammation activation resulting in adventitial cell proliferation and migration. However, the detailed mechanism remains to be further investigated. We then showed that blockade of Flt-1 signaling remarkably suppresses OPN expression in injured arteries. Our finding is consistent with previous studies that OPN plays an important role in neointima formation after arterial injury in vivo. 24, 44 Dai et al 45 reported that OPN induces VEGF expression, which in turn regulates angiogenesis, whereas we demonstrated that VEGF enhances OPN expression in adventitia of injured arteries suggests there could be a positive feedback loop between VEGF and OPN, which might aggravate adventitia-mediated vascular inflammation and subsequent remodeling after injury.
In vascular inflammation, the recruitment of macrophages into the adventitia of large conduit arteries that occurs in parallel with the development of hypertrophy of the vascular wall is consistent with our finding. 4, 46 Several studies demonstrated that VEGF is a potent proinflammatory factor, 47, 48 which is an essential mediator in angiotensin II-induced vascular inflammation through its proinflammatory actions, 49 and endogenous VEGF accelerates macrophage-mediated inflammation by regulating monocyte chemoattractant protein-1 expression. 40 Moreover, Flt-1 has been shown to act as an important mediator of VEGF-induced inflammation. 14, 48, 50 Our previous study demonstrated that the expression of Flt-1 was upregulated in AFs by angiotensin II and in adventitia after balloon injury suggesting that VEGF/Flt-1 signaling might play an important role in vascular inflammation after injury. 17 In the present study, we further demonstrated that anti-Flt-1 peptide attenuates increased VEGF expression, indicating that VEGF regulates VEGF/Flt-1 signaling to accelerate the inflammatory process by an autocrine loop mechanism in adventitia of injured arteries. In conclusion, the present study provided a new indication that VEGF/Flt-1 signaling mediates adventitia-mediated vascular inflammation by upregulating OPN expression and Flt-1 might serve as a potential therapeutic target for vascular diseases.
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